Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling. Cancer Med. 2019 12; 8(17):7322-7329.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Androgen Receptor Antagonists
Androgen Receptor Antagonists
Antineoplastic Agents
Antineoplastic Agents
B7-H1 Antigen
B7-H1 Antigen
Biomarkers, Tumor
Biomarkers, Tumor
Biopsy
Biopsy
Carcinoma, Ductal
Carcinoma, Ductal
Class I Phosphatidylinositol 3-Kinases
Class I Phosphatidylinositol 3-Kinases
Cohort Studies
Cohort Studies
Gene Expression Profiling
Gene Expression Profiling
High-Throughput Nucleotide Sequencing
High-Throughput Nucleotide Sequencing
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Male
Male
MAP Kinase Signaling System
MAP Kinase Signaling System
Middle Aged
Middle Aged
Molecular Targeted Therapy
Molecular Targeted Therapy
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Patient Selection
Patient Selection
Protein Isoforms
Protein Isoforms
Receptor, ErbB-2
Receptor, ErbB-2
Receptors, Androgen
Receptors, Androgen
Salivary Ducts
Salivary Ducts
Salivary Gland Neoplasms
Salivary Gland Neoplasms